š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study was conducted to obtain safety and immunogenicity data after a b...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01245751
Treatments Being Tested
This study will compare the safety and immunogenicity of ZOSTAVAXā¢ (V211) a...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01385566
The purpose of this study is to determine whether Zoster Vaccine Live and P...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00535730
A study in two parts (Part A and Part B) to evaluate the responsiveness of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00886613
Treatments Being Tested
This study will evaluate the safety, tolerability, and immunogenicity of ZO...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01556451
Treatments Being Tested
In this study the investigators are trying to identify immune signatures th...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2010-09
Trial ID
NCT01911065
Treatments Being Tested
The purpose of this study is to determine whether the investigational zoste...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00231816
Treatments Being Tested
This study will look at how well Zostavaxā¢ works in preventing shingles in ...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00534248
Treatments Being Tested
The purpose of this study is to assess immunogenicity, reactogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-03
Trial ID
NCT01954251
This study will determine if ZOSTAVAXā¢ is safe, tolerable, and immunogenic ...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-31
Trial ID
NCT01527370
Treatments Being Tested